Correlation Between Syndax Pharmaceuticals and Abcellera Biologics

Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Syndax Pharmaceuticals and Abcellera Biologics, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Abcellera Biologics.

Diversification Opportunities for Syndax Pharmaceuticals and Abcellera Biologics

-0.27

Correlation Coefficient

Syndax Pharmaceuticals  Abcellera Biologics

Very good diversification

The 3 months correlation between Syndax and Abcellera is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Abcellera Biologics go up and down completely randomly.

Pair Corralation between Syndax Pharmaceuticals and Abcellera Biologics

Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to under-perform the Abcellera Biologics. In addition to that, Syndax Pharmaceuticals is 1.09 times more volatile than Abcellera Biologics. It trades about -0.07 of its total potential returns per unit of risk. Abcellera Biologics is currently generating about 0.03 per unit of volatility. If you would invest  275.00  in Abcellera Biologics on September 18, 2024 and sell it today you would earn a total of  11.00  from holding Abcellera Biologics or generate 4.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Syndax Pharmaceuticals  vs.  Abcellera Biologics

Syndax Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Syndax Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Abcellera Biologics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite quite inconsistent fundamental indicators, Abcellera Biologics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Syndax Pharmaceuticals and Abcellera Biologics

The main advantage of trading using opposite Syndax Pharmaceuticals and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.

The idea behind Syndax Pharmaceuticals and Abcellera Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.